Canada Markets closed

CVS Health Corporation (CVS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
100.88+0.47 (+0.47%)
At close: 04:00PM EST
100.88 0.00 (0.00%)
After hours: 07:43PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.71
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3111.25
52 Week Low 386.28
50-Day Moving Average 396.12
200-Day Moving Average 398.79

Share Statistics

Avg Vol (3 month) 35.96M
Avg Vol (10 day) 35.08M
Shares Outstanding 51.32B
Implied Shares Outstanding 6N/A
Float 81.31B
% Held by Insiders 10.38%
% Held by Institutions 179.99%
Shares Short (Oct 13, 2022) 412.52M
Short Ratio (Oct 13, 2022) 42.18
Short % of Float (Oct 13, 2022) 40.95%
Short % of Shares Outstanding (Oct 13, 2022) 40.95%
Shares Short (prior month Sept 14, 2022) 414.38M

Dividends & Splits

Forward Annual Dividend Rate 42.2
Forward Annual Dividend Yield 42.37%
Trailing Annual Dividend Rate 32.00
Trailing Annual Dividend Yield 31.99%
5 Year Average Dividend Yield 42.82
Payout Ratio 434.20%
Dividend Date 3Oct 31, 2022
Ex-Dividend Date 4Oct 19, 2022
Last Split Factor 22:1
Last Split Date 3Jun 06, 2005

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022


Profit Margin 2.66%
Operating Margin (ttm)4.71%

Management Effectiveness

Return on Assets (ttm)3.91%
Return on Equity (ttm)10.94%

Income Statement

Revenue (ttm)306.93B
Revenue Per Share (ttm)233.05
Quarterly Revenue Growth (yoy)11.30%
Gross Profit (ttm)50.85B
Net Income Avi to Common (ttm)8.17B
Diluted EPS (ttm)5.46
Quarterly Earnings Growth (yoy)6.00%

Balance Sheet

Total Cash (mrq)14.99B
Total Cash Per Share (mrq)11.42
Total Debt (mrq)74.17B
Total Debt/Equity (mrq)98.23
Current Ratio (mrq)0.91
Book Value Per Share (mrq)52.97

Cash Flow Statement

Operating Cash Flow (ttm)18.53B
Levered Free Cash Flow (ttm)14.16B